Roadmap Epigenomics Project graphic identity

Program Snapshot

The Epigenomics program has transitioned from Common Fund support. Common Fund programs are strategic investments that achieve a set of high-impact goals within a 5-10 year timeframe. At the conclusion of each program, deliverables transition to other sources of support or use within the scientific community.

Please note that since the Epigenomics program is no longer supported by the Common Fund, the program website is being maintained as an archive and will not be updated on a regular basis.

The Epigenomics program was supported by the Common Fund from 2008 to 2017. Currently, Roadmap-developed datasets are available through the Roadmap Epigenomics Mapping Consortium website, the ENCODE website, IHEC, and the Baylor Epigenome Atlas. During the period of program funding, there was a significant increase in the funding and study of Epigenomics, a diversification in topics of funded Epigenomics projects, and an increase in the types of diseases linked to epigenomic changes.

Highlights of the Epigenomics program’s major accomplishments are:

  • Completion of 111 reference epigenomes in a variety of healthy human cells and tissues

  • Development of mammalian whole genome bisulfite sequencing for DNA methylation determination

  • Development of epigenomic metadata and data standards that have been adopted by the scientific community

  • Enabling human in vivo epigenetic enzyme imaging using PET

  • Advancing functional epigenomic manipulation using CRISPR

  • Generation of over 2,600 data sets used to predict tissue-specific patterns of human disease

  • Discovered new epigenetic marks, including novel histone modifications

The Common Fund's Epigenomics Program generated a set of reference epigenomes and new research tools, technologies, datasets, and infrastructure that accelerated our understanding of how genome-wide chemical modifications to DNA regulate gene activity without altering the DNA sequence itself and what role these modifications play in health and disease.

The Roadmap Epigenomics program issued its first round of awards in 2008. The program issued 77 awards and produced 111 reference maps of epigenomic modifications in a variety of healthy human cells and tissues, as well as other resources and tools that are extensively used by the biomedical research community. The Roadmap datasets are available through the Roadmap Epigenomics Mapping Consortium website, the ENCODE website, IHEC, and the Baylor Epigenome Atlas. Over 230 publications have cited use of Roadmap Epigenomics program data, with publications covering a wide range of topics. The Roadmap Epigenomics program became a founding member of the International Human Epigenome Consortium (IHEC) in 2010, which has significantly enhanced global funding and coordination of epigenomic research. Roadmap Epigenomics awardees published over 800 peer-reviewed articles. An integrative analysis paper, together with more than 20 companion papers, was published in a 2015 special edition of Nature. Program funding ended in 2017.

A Scientific Illustration of How Epigenetic Mechanisms Can Affect Health

Epigenomics Resources


This page last reviewed on January 30, 2019